inVentiv Looks To Refi, Fund Deal
inVentiv Health is tapping the loan market for an acquisition and refinancing.
inVentiv Health is tapping the loan market for an acquisition and refinancing. UBS and Bank of America lead the facility, which comprises a six-year, $50 million revolver; a seven-year, $330 million first-lien term loan and a seven-year, $20 million delayed-draw term loan. Pricing is LIBOR plus 1 3/4% ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com